Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
07/2007
07/04/2007EP1802585A1 4-substituted 4,6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms
07/04/2007EP1802572A1 Indol derivatives as inhibitors of soluble adenylyl cyclase
07/04/2007EP1802307A1 Pyrrolidine derivatives as histamine receptors ligands
07/04/2007EP1644343B1 5-substituted quinazolinone derivatives
07/04/2007EP1484971B1 Use of 4-aminopyrimidines for the antimicrobial treatment of surfaces
07/04/2007EP0977750B1 Farnesyltransferase inhibiting quinazolinones
07/04/2007CN1993356A Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase
07/04/2007CN1993355A Purification of olmesartan medoxomil
07/04/2007CN1993354A Preparation of hydrochloride salts of tetrazole derivative
07/04/2007CN1993324A 3-(((4-phenyl)-piperazin-1-yl)-alkyl)-3-alkyl-1,3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders
07/04/2007CN1993319A Benzyloxy derivatives as MAOB inhibitors
07/04/2007CN1993123A Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
07/04/2007CN1990474A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
07/04/2007CN1990470A Phthiobuzonum derivative, its manufacturing process, pharmaceutical combination and uses thereof
07/04/2007CN1990469A Pyrrolidines as dipeptidyl peptidase inhibitors
07/04/2007CN1990468A Pyrrolidines as dipeptidyl peptidase inhibitors
07/04/2007CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
07/04/2007CN1324023C 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
07/04/2007CN1324015C Pyridine and pyrimidine derivatives
07/03/2007US7238813 Antiproliferative agents; angiogenesis factor; wound healing agents; antiischemic agents; anticholesterol agents; antitumor, anticancer agents
07/03/2007US7238724 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
07/03/2007US7238723 Indole derivatives
07/03/2007US7238721 Pyrazole compounds for treatment of neurodegenerative disorders
07/03/2007US7238720 Pharmaceutical use of N-carbamoylazole derivatives
07/03/2007US7238716 Alkanoic acid derivatives process for their production and use thereof
07/03/2007US7238699 Imidazolyl derivatives as corticotropin releasing factor inhibitors
07/03/2007US7238696 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
07/03/2007US7238695 Imidazolyl derivatives
07/03/2007US7238693 Gastrointestinal disorders; central nervous system disorders; cardiovascular disorders
07/03/2007US7238692 Stent or a drug delivery or elution device with a disposed traiazine compound such as 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4-diamine for inhibiting smooth muscle proliferation; restenosis and atherosclerosis
07/03/2007US7238688 For therapy of allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep
07/03/2007US7238687 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
07/03/2007US7238685 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating vasoconstriction, proliferation and inflammation
07/03/2007US7238683 (Cycloalkyleneiminocarbonyl)-indanyl- or -tetrahydronaphthyl- methylamines, e.g., {(1S)-1-[(1S)-5-(4-Fluorophenyl)-2,3-dihydro-1H-inden-1-yl]-2-[(3S)-3-fluoropyrrolidin-1-yl]-2-oxoethyl}amine hydrochloride; particularly for treating type 2 diabetes
07/03/2007US7238682 Two two hsp-binding ansamycin antibiotic moieties connected to one another by a linker that bind to the pocket of hsp90 and are effective for inducing the degradation and/or inhibition of HER-family tyrosine kinases; used for treating HER-positive cancers with reduced toxicity
07/03/2007US7238679 novel family of quinazolines (and pharmaceutically acceptable derivatives thereof that have a range of useful biological and pharmacological properties
07/03/2007CA2359092C Novel cationic oxidation bases, their use for dyeing keratin fibres, dyeing compositions and dyeing methods
06/2007
06/28/2007WO2007073300A1 Gaba-b receptor modulators
06/28/2007WO2007073283A1 Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis
06/28/2007WO2007072999A1 Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same
06/28/2007WO2007072476A2 Methods of preparing a crystalline form of 7-(4-chlorobutoxy)-3,4-dihydro-2(1h)-quinolinone and the use thereof in the synthesis of aripiprazole
06/28/2007WO2007071963A2 Quinazoline derivatives, process for their preparation and their use as anti-cancer agents
06/28/2007WO2007071952A1 Piperazine compounds useful as antagonists of c-c chemokines (ccr2b and ccr5) for the treatment of inflammatory diseases
06/28/2007WO2007071662A1 4,5-dihydro- (1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators
06/28/2007WO2007071646A1 Novel substituted pyrazinone derivatives for use in mch-1 mediated diseases
06/28/2007WO2007071455A1 Sulfoximine-substituted pyrimidines , their preparation and use as drugs
06/28/2007WO2007071400A1 Pyrazine derivatives as epithelial sodium channel blocker
06/28/2007WO2007071396A2 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions
06/28/2007WO2007071358A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors
06/28/2007WO2007071023A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
06/28/2007WO2007053499A3 Compounds useful as antagonists of ccr2
06/28/2007WO2007048065A3 Pyrimidinones as casein kinase ii (ck2) modulators
06/28/2007WO2007026920A3 Amide derivatives as rock inhibitors
06/28/2007WO2007022938A3 Compounds
06/28/2007WO2006116412A3 Fused heterocyclic compounds
06/28/2007WO2004000210A3 Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives
06/28/2007US20070149782 Methods of preparing a crystalline form of 7-(4-chlorobutoxy)-3,4-dihydro-2(1h)-quinolinone and the use thereof in the synthesis of Aripiprazole
06/28/2007US20070149780 Process for preparing haloalkyl(thio)vinimidinium salts and 4-(haloalkyl(thio))pyrazoles and their conversion to crop protection compositions
06/28/2007US20070149606 Process for producing phenylacetic acid derivative
06/28/2007US20070149605 Substituted pyrrole derivatives as hmg-coa reductase inhibitors
06/28/2007US20070149602 exhibit an in vitro and in vivo antagonist activity for receptors of TRPV1 (Transient receptor potential vanilloid) (or VR1) type; pain and irritation of the skin, eyes and mucous membrane;
06/28/2007US20070149601 Bis-indole pyrroles useful as antimicrobials agents
06/28/2007US20070149598 M3 muscarinic acetylcholine receptor antagonists
06/28/2007US20070149586 New crystalline and stable form of andolast
06/28/2007US20070149575 5-Aminoalkylpyrazole derivatives as pesticidal agents
06/28/2007US20070149574 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity
06/28/2007US20070149573 99.9% By weight of amorphous S-omeprazole magnesium, <0.1% by weight of impurities as determined by liquid chromatography; X-ray powder diffractogram; substantially free of neutral omeprazole; optical purity 94-96% e.e.; anhydrous; industrial scale; materials handling; filterable
06/28/2007US20070149571 Combination therapy for treating or managing acute myelocytic leukemia
06/28/2007US20070149565 Nelfinavir conjugates and antibodies useful in immunoassay
06/28/2007US20070149556 Hydroxypyrimidinone derivatives having inhibitory activity against hiv integrase
06/28/2007US20070149551 crop protection agents for controlling harmful fungi; improved activity; [6-chloro-2-(N'-isopropylidene-hydrazino)-5-(2,4,6-trifluorophenyl)pyrimidine-4-yl]-((S)-1-tri-fluoromethylethyl)amine; against Septoria Leaf Blotch of Wheat, Net Blotch of Barley and Mildew of Cucumber
06/28/2007US20070149550 Substituted arylpyrazoles
06/28/2007US20070149547 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
06/28/2007US20070149546 4-Anilino-quinazoline derivatives as antiproliferative agents
06/28/2007US20070149541 Imidazole compounds
06/28/2007US20070149538 Diarylamine-Containing Compounds and Compositions, and their use as Modulators of C-Kit Receptors
06/28/2007US20070149536 2-[4-Bromomethyl)phenyl-3-phenylquinoxaline 1-2; selectively inhibits one or two of the serine/threonine protein kinase isoforms; antiproliferative
06/28/2007US20070149533 Bicyclic compounds with kinase inhibitory activity
06/28/2007US20070149532 3-Aminocyclopentanecarboxamides as Modulators of Chemokine Receptors
06/28/2007US20070149531 Antiviral agents
06/28/2007US20070149530 Antiviral agents
06/28/2007US20070149529 inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, autoimmune pathologies such as rheumatoid arthritis and atherosclerosis
06/28/2007US20070149528 rheumatoid arthritis, systemic lupus erythematosus (SLE), idiopathic (immune) thrombocytopenia (ITP), glomerulonephritis and vasculitis; reduced drug toxicity
06/28/2007US20070149516 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide
06/28/2007US20070149514 Indole-phenylsulfonamide derivatives used as ppar-delta activating compounds
06/28/2007US20070149513 Vanilloid receptor ligands and their use in treatments
06/28/2007US20070149508 Six membered heteroaromatic inhibitors targeting resistant kinase mutations
06/28/2007US20070149503 Anti-migraine spirocycles
06/28/2007US20070149502 Spirocyclic anti-migraine compounds
06/28/2007US20070149500 Compounds, compositions, and methods
06/28/2007US20070149406 5-substituted-1-arylpyrazole-3-carboxylic acid derivatives
06/28/2007US20070148708 Protease inhibitor conjugates and antibodies useful in immunoassay
06/28/2007US20070148093 Non-terminal method of identifying anti-migraine compounds
06/28/2007DE102005062742A1 Sulfoximin substituierte Pyrimidine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel Sulfoximine substituted pyrimidines, process for their preparation and their use as medicaments
06/28/2007CA2634305A1 Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis
06/28/2007CA2633207A1 Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same
06/28/2007CA2632936A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
06/28/2007CA2632929A1 Quinazoline derivatives, process for their preparation and their use as anti-cancer agents
06/28/2007CA2632881A1 Sulfoximine-substituted pyrimidines, their preparation and use as drugs
06/28/2007CA2632582A1 4,5-dihydro- (1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators
1 ... 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 ... 626